Aytu Bioscience Inc (NASDAQ:AYTU) reached a new 52-week low during trading on Thursday . The company traded as low as $1.00 and last traded at $1.06, with a volume of 2311 shares trading hands. The stock had previously closed at $1.11.
Separately, Northland Securities initiated coverage on Aytu Bioscience in a research report on Monday, October 22nd. They issued an “outperform” rating and a $10.00 price target on the stock.
The stock has a market cap of $2.00 million, a P/E ratio of -0.03 and a beta of 6.25.
Aytu BioScience, Inc, a specialty healthcare company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and ZolpiMist, an oral spray for the treatment of insomnia.
Featured Article: Bond
Receive News & Ratings for Aytu Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.